10/1/24 – DAC A/V project scope meeting – City staff, Durotech, DataVox, BSW 10/3/24 – Girls' softball parking lot punch list walkthrough – City staff, Turner Paving 10/3/24 – Internal meeting to discuss status of DPCDC projects – City Staff 10/4/24 – Pickleball Courts scope discussion – City staff 10/8/24 – Glenwood Park construction meeting – City Staff, MHS计划,卢卡斯·康斯特(Lucas Const)。10/8/24 – Deer Park Community Center construction meeting – City Staff, Durotech, BSW 10/14/24 - Discussion of CDC projects updates at the monthly PARC meeting – City staff, PARC 10/17/24 – Internal meeting to discuss status of DPCDC projects – City Staff 10/22/24 - Deer Park Community Center construction meeting – City Staff, Durotech, BSW 10/22/24 – Glenwood Park construction meeting –市政工作人员,MHS计划,卢卡斯·康斯特(Lucas Const)。10/22/24 - DAC池前建设会议 - 城市工作人员,Durotech 10/23/24 - Spencerview Bridge Bridge Pre-Bid会议 - Cobbfendley 10/30/24/24/24-24/24 - Pickleball Court讨论 - 市政府工作人员 - TF Harper,TF Harper 10/31/24 - 内部会议,讨论DPCDC PARMATES dpcdc PARY-dpcdc at cd of CDCD-4/4/4/4/dpcd ot cd of CDC of CD CD cd of CDCD-4/4/4/ - 城市工作人员,PARC,11/5/24 - Glenwood Park建筑会议 - 市政工作人员,MHS计划,Lucas Const。12/3/24 – DAC construction meeting – City Staff, Durotech, BSW 12/3/24 – DAC Business Plan presentation – City Staff 12/10/24 – DAC site visit – City Staff, Durotech 12/12/24 – Internal meeting to discuss status of DPCDC projects – City Staff 12/17/24 – Glenwood Park construction meeting – City Staff, MHs Planning, Lucas Const.24年11月5日 - Spencerview Bridge BID开放 - Cobbfendley 11/5/24 - 鹿公园社区中心建筑会议 - 市政工作人员,BSW,BSW 11/5/24-24/5/24 - Pickleball Court Design讨论讨论 - 市政府工作人员11/8/24/24/24-24/DAC营销计划 - DAC营销计划 - 市政员工会议 - 市政员工11/13/13/11/13/DAC BUFFED - DAC BUFFED -BEDICK ERDITION - DAC BUDGED -14/DAC BUFFE -DAC,DAC 11/14/DAC,DAC -14/DAC,DAC -14/ BSW 11/15/24 – Glenwood Park site visit – City Staff, MHS Planning, Lucas Construction 11/19/24 – DAC construction meeting – City Staff, Durotech, BSW 11/21/24 – Review RFQ for Dow Park pipeline project – City Staff 11/22/24 – Glenwood Park contingency options meeting – City Staff, MHS Planning 12/2/24 – Discussion of CDC projects updates at the monthly PARC meeting - 城市工作人员,PARC 12/3/24 - Glenwood Park建设会议 - 市政工作人员,MHS计划,Lucas Const。12/17/24 – DAC construction meeting – City Staff, Durotech, BSW 12/18/24 – RFQ for Dow park pipeline project evaluation review – City staff 12/23/24 – Glenwood Park site visit – City Staff, MHS Planning, Lucas Construction 12/31/24 – Glenwood Park construction meeting – City Staff, MHs Planning, Lucas Const.
Post-transplant malignancies arise from a complex interplay of factors, with immunosuppression playing a pivotal role. Chronic immunosuppressive treatment compromises the recipient's immune system, rendering it less efficient at recog- nizing and eliminating malignant cells. Additionally, viral infections, especially Epstein–Barr virus and Human papilloma- virus, are major contributors to malignancy development. Lifestyle modifications, including smoking cessation and sun protection, are recommended for reducing certain cancer risks. Regular screening for malignancies may provide the early diagnosis as in the general population. After the diagnosis of cancer, tailoring immunosuppressive regimens to maintain graft function is crucial. Treatment options, such as chemotherapies, targeted therapies, and immunotherapies, should be selected with consideration of the patient's overall health and the potential impact on the transplanted organ. A multidis- ciplinary approach is required in order to provide optimal treatment to our kidney transplant recipients. With this review article, we aim to discuss pathophysiological mechanisms, review guidelines, and provide information on the incidence and management options for various cancers. Keywords: Immune checkpoint inhibitors, malignancy, prevention, kidney transplantation, screening
本课程让学生了解药学研究中的当前生物制药的关键知识和技 术。它涵盖了生物技术制药过程中涉及的药物设计、合成与生 产、筛选与评价及应用,并且包括新兴生物制药技术合理药物递 送方式、部分生物技术制药相关实验等。本课程将介绍不同生物 技术与实验用于制药的案例,学生将在其中了解生物技术制药研 究现状及相关技术操作。 Learning Outcomes By the end of this course, each student should be able to describe and discuss: • Historical background, current development and future trends of biotech-based pharmaceuticals • Major engineering techniques, applications and differences between biopharmaceuticals and traditional chemical pharmaceuticals • Classification, characteristics and general rules of emerging biotech-based drug development • Basic principles, applications and cases of emerging biotech-based pharmaceuticals • The latest development trends and technological advances in biotech-based drug development • Biotech-based drug development process, including design, synthesis, screening and evaluation, and rational drug delivery methods and technologies • Typical biopharmaceutical experimental steps, operations, precautions and data analysis
摘要:小胶质细胞,中枢神经系统的免疫细胞是调节脑发育和脑部健康的关键元素。这些细胞对压力源,微环境改变充分响应,并积极参与儿童的神经回路的构建以及成人完全依赖经验的可塑性的能力。由于神经蛋白的流量是COVID-19的发病机理中的已知关键元素,因此人们可能期望小胶质细胞功能的失调会严重影响功能和结构可塑性,从而导致长相变速器发作的认知后遗症。因此,理解这种复杂情况是建立与这些症状相关的可能分子机制的必不可少的。In the present review, we will discuss Long COVID and its association with reduced levels of BDNF, altered crosstalk between circulating immune cells and microglia, increased levels of inflammasomes, cytokines and chemokines, as well as the alterations in signaling pathways that impact neural synaptic remodeling and plasticity, such as fractalkines, the complement system, the expression of SIRP α and CD47分子和矩阵重塑。在一起,这些复杂的机制可能有助于我们了解长期脑发育的后果及其与大脑可塑性的关联,影响学习障碍,神经发育障碍以及成人的认知能力下降。
神经退行性疾病的特征是神经元结构和功能的进行性分解以及错误折叠的蛋白质聚集体和有毒蛋白质低聚物的病理积累。神经元生理恶化的主要因素是蛋白酶体介导的蛋白质分解代谢途径的破坏,蛋白酶体是一种大多数细胞蛋白质降解的大蛋白酶复合物。以前,人们认为蛋白酶体需要用多泛素链标记蛋白质靶标,这是一种称为泛素蛋白 - 蛋白酶体系统(UPS)的途径。因此,大多数关于蛋白酶体在神经变性中作用的研究历史上都集中在UPS上。然而,越来越多地认识到额外的泛素独立途径及其在神经变性中的重要性。In this review, we discuss the range of ubiquitin-independent proteasome pathways, focusing on substrate identi fi cation and targeting, regulatory molecules and adaptors, proteasome activators and alternative caps, and diverse proteasome complexes including the 20S proteasome, the neuronal membrane proteasome, the immunoproteasome, extracellular proteasomes, and hybrid蛋白酶体。在衰老,氧化应激,蛋白质聚集和与年龄相关的神经退行性疾病的背景下进一步讨论了这些途径,并特别关注阿尔茨海默氏病,亨廷顿病和帕金森病。对神经退行性中泛素独立的蛋白酶体功能的机理理解对于开发治疗这些毁灭性疾病的疗法至关重要。本综述总结了神经变性中泛素独立的蛋白酶体研究的当前状态。
This course aims at introducing the basic concepts and techniques in carrying out chemical analysis by using various modern spectroscopic and chromatographic instruments.Students will learn how to use modern instruments to determine the amounts of substances present in a mixture down to part per million levels (ppm), and identify the structure of a compound.Techniques such as UV-visible spectroscopy, infrared spectroscopy, mass spectrometry, nuclear magnetic resonance spectroscopy, gas chromatography and high performance liquid chromatography will be covered.This course will also discuss some common standard practices of collecting and preparing samples for laboratory testing, the accreditation system in testing laboratories.This course is conducted in the format of lecture.本课程旨在介绍化学分析中所用到的现代光谱和色谱仪器的基本概念和技术。学生将学习使用该 等仪器来分析浓度水平低至百万分之一的物质,并确定化合物的结构。课程内容包括紫外 − 可见光 谱法、红外线光谱法、质谱分析法、核磁共振、气相色谱法及高效能液相色谱法的操作技巧,以 及化验工作中的收集及制备样本的常用标准技巧和香港化验室所实行的认可系统。课程以讲课形 式进行。 Medium of Instruction:
癌症是一种毁灭性的疾病,与正常细胞相比,癌细胞的能量和物质利用能力强大。这部分是由于能够根据环境变化来调整其新陈代谢的能力。在癌细胞的寿命中,在癌变,进度或转移中观察到巨大的能量和物质需求。但是,涉及的机制是有争议的,尚不清楚。了解癌细胞如何比正常细胞捕获更多的能量和物质,对于开发下一代癌症治疗,包括寻找新的药物靶标和设计药物。最近通过与正常细胞和细胞质中分级的使者池相连的自组装蛋白纳米管的癌细胞线粒体劫持的最新报道引起了极大的兴趣。考虑到这种角度考虑了物理和化学区域中广泛讨论的纳米域,因此对生物纳米限制(BNC)进行了合理讨论。We discuss various aspects such as the tendency of solid cancer cells to prioritize and utilize energy and substances at hypoxia while creating a lesser nutrition-supplying environment extra- and intra-cellularly, the paradox that chimeric antigen receptor T (CAR-T) therapies are effective in hematological cancers but less effective in solid tumors, and the fact that CAR-T adjuvant therapy with chemotherapy has synergetic enhancement效果。此外,我们得出的结论是,迫切需要开发新型抑制剂以解散生物纳米浓缩。
如何制定紧急操作计划?在狭窄的空间中讨论安全性。讨论由于缺氧引起的安全危害。描述厌氧消化器运行中的安全措施。讨论“后挡板”安全会议。讨论对制定安全计划很重要的文书工作。什么是胺?在废水处理厂讨论表面活性剂。讨论所需的安全设备和耗材。讨论MSD(现为SDS)。描述狭窄空间的大气危害。定义限制空间。在废水场中可能会遇到哪些有毒气体。可以总是通过气味检测到硫化氢气体吗?如果不是,原因是什么?描述易燃/爆炸气。讨论氧气不足大气的危害。进入限制空间需要什么预防措施?在检查和采样期间可能会遇到哪些危险材料?在检查和采样期间可能会遇到哪些腐蚀性材料?废水处理厂可能会遇到哪些腐蚀性材料?
discussion. To prepare for these discussions, you need to read the case beforehand (which I will remind you to do as we go). Cases hinge critically on students having read in advance, so to get a sense of whether students have read the cases, we will typically start with some basic ‘reading check' questions about the case content. I plan for these checks to be informal, but if I get the sense that students are not reading the cases ahead of time, I reserve the right to institute more formal “case quizzes.” HOMEWORK In addition to reading the cases and coming prepared for class discussions, your primary homework in this course will be competing in the MarkStrat simulation (see below). Specifically, you and your teammates will be required to submit seven weekly “decisions” about how to manage a simulated suite of products in a competitive market, competing against your classmates. These decisions will include what products to develop and bring to market, how to advertise them, where to sell them, and what market research to procure for future periods. Decisions will typically be due on Tuesdays and we will discuss the results of them—which impact your grade—weekly in class on Wednesdays. As you will see, the simulation cannot accept late decisions by design. In addition to these seven decisions, you will be asked to complete a short (~5ish) paper assignment as a team to demonstrate your mastery of the simulation at the end of the semester. MARKSTRAT (GROUP WORK) As indicated, the central assignment in this class is a team-based simulation, MarkStrat. You will be assigned by me to teams of 4-5 students and you will need to find time to work together (either
是退伍军人卫生管理局(VHA)政策,每个退伍军人事务部(VA)医疗机构主管必须向所有工作人员提供书面通知,包括医疗事务所成员的医疗事故索赔,包括承包商和卫生教授培训生(HPTS),由VA医疗机构识别为基于Care涉及的侵权索赔,这些索赔是基于该索赔的侵权索赔。VHA政策也是确保索赔人被告知侵权索赔表上列出的任何工作人员的雇用状况,标准表(SF)95“损害,伤害或死亡的索赔”。注意:该指令确保遵守对VHA工作人员的通知的法定要求,他们的关心是指称医疗事故索赔的主题,以及对总法律顾问办公室(OGC)侵权行为组织(TLG)。该指令不讨论向患者或其家人披露不良事件的披露;该信息可在VHA指令1004.08,向患者披露,日期为2018年10月31日。This directive also does not discuss either the tort claim post-payment review process that is administered by the VHA Office of Medical- Legal Risk Management (MLRM) or the National Practitioner Data Bank (NPDB) reporting required following an adverse clinical privileges action against a physician or dentist (see VHA Handbook 1100.17, National Practitioner Data Bank (NPDB) Reports, dated December 28, 2009).权威:P.L。116-315,§7010; 38 U.S.C.§7301(b)。